NMR structure of the human oncofoetal fibronectin ED-B domain, a specific marker for angiogenesis

Structure

Volumn 7, Issue 4, 1999, Pages 381-390

  Fattorusso, Roberto ^a,c   Pellecchia, Maurizio ^a,d   Viti, Francesca ^a   Neri, Paolo ^b   Neri, Dario ^a   Wüthrich, Kurt ^a  

^a ETH ZURICH   (Switzerland)

^b UNIVERSITY OF SIENA   (Italy)

^c SECOND UNIVERSITY OF NAPLES   (Italy)

^d UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Angiogenesis marker; ED B domain; Fibronectin isoform; NMR

Indexed keywords

FIBRONECTIN;

ALTERNATIVE RNA SPLICING; ANGIOGENESIS; ARTICLE; DISEASE MARKER; EPITOPE MAPPING; EYE DISEASE; HUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; RHEUMATOID ARTHRITIS; STRUCTURE ANALYSIS; THREE DIMENSIONAL IMAGING;

EID: 0033560794     PISSN: 09692126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-2126(99)80051-3     Document Type: Article

References (57)

1. Folkman, J. (1995). Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Med. 1, 27-31.
2. O'Reilly, M.S., Holmgren, L., Chen, C. & Folkman, J. (1996). Angiostatin induces and sustains dormancy of human primary tumors in mice. Nature Med. 2, 689-692.
3. Huang, H., Molema, G., King, S., Watkins, L., Edgington, T.S. & Thorpe, P.E. (1997). Tumor infarction in mice by antibody-directed targeting of tissue factor to tumor neovasculature. Science 275, 547-550.
4. Neri, D., et al., & Winter, G. (1997). Targeting by affinity-matured recombinant antibody fragments of an angiogenesis associated fibronectin isoform. Nature Biotechnol. 15, 1271-1275.
5. Pasqualini, R., Koivunen, E. & Ruoslahti, E. (1997). αv integrins as receptors for tumor targeting by circulating ligands. Nature Biotechnol. 15, 542-546.
6. Zetter, B.R. (1997). On target with tumor blood vessel markers. Nature Biotechnol. 15, 1243-1244.
7. Zardi, L., et al., & Baralle, F.E. (1987). Transformed human cells produce a new fibronectin isoform by preferential alternative splicing of a previously unobserved exon. EMBO J. 6, 2337-2342.
8. Hynes, R.O. (1990). Fibronectins. Springer-Verkag, New York.
9. Carnemolla, B., et al., & Zardi, L. (1996). Phage antibodies with pan-species recognition of the oncofoetal angiogenesis marker fibronectin ED-B domain. Int. J. Cancer 68, 397-405.
10. Bork, P. & Doolittle, R. (1992). Proposed acquisition of an animal protein domain by bacteria. Proc. Natl Acad. Sci USA 89, 8990-8994.
11. Castellani, P., et al., & Zardi, L. (1994). The fibronectin isoform containing the ED-B oncofoetal domain: A marker of angiogenesis. Int. J. Cancer 59, 612-618.
12. Wüthrich, K. (1986). NMR of Proteins and Nucleic Acids. Wiley, New York.
13. Fesik, S.W. & Zuiderweg, E.P.R. (1988). Heteronuclear three-dimensional NMR spectroscopy. A strategy for the semplification of homonuclear two-dimensional NMR spectra. J. Magn. Reson. 78, 588-593.
14. Canavagh, J., Fairbrother, W.J., Palmer A.G.III. & Skelton, N.J. (1996). Protein NMR Spectroscopy, Principles and Practice. pp. 394-395, Academic Press, San Diego.
15. AB-COSY. J. Magn. Reson. 93, 218-224.
16. β resonance in larger proteins. J. Magn. Reson. 95, 636-641.
17. 1H spin system identification in macromolecules. J. Am. Chem. Soc. 110, 7870-7872.
18. Nagayama, K., Kumar, A., Wüthrich, K. & Ernst, R.R. (1980). Experimental techniques of two-dimensional correlated spectroscopy. J. Magn. Reson. 40, 321-324.
19. Kumar, A., Ernst, R.R. & Wüthrich, K. (1980). A two-dimensional nuclear overhauser enhancement (2D NOE) experiment for the elucidation of complete proton-proton cross-relaxation networks in biological macromolecules. Biochem. Biophys. Res. Commun. 95, 1-6.
20. 13C labelling. FEBS Lett. 249, 113-118.
21. 13C labeling. Biochemistry 28, 7510-7516.
22. Güntert, P., Billeter, M., Ohlenschlager, O., Brown, L.R. & Wüthrich, K. (1998). Conformational analysis of protein and nucleic acid fragments with the new gridsearch algorithm FOUND. J. Biomol. NMR 12, 543-548.
23. Plateau, P. & Gueron, M. (1982). Exchangeable proton NMR without base-line distortion, using new strong-pulse sequences. J. Am. Chem. Soc. 104, 7310-7311.
24. Szyperski, T., Güntert, P., Otting, G. & Wüthrich, K. (1992). Determination of scalar coupling constants by inverse Fourier transformation of in-phase multiplets. J. Magn. Reson. 99, 552-560.
25. 15N-labeled proteins: Application to the photoactive yellow protein. J. Biomol. NMR 10, 301-306.
26. Chan, A.W.E., Hutchinson, E.G., Harris, D. & Thornton, J.M. (1993). Identification, classification, and analysis of β-bulges in protein. Protein Sci. 2, 1574-1590.
27. Pini, A., et al., & Neri, D. (1998). Design and use of a phage display library: Human antibody with subnanomolar affinity against a marker of angiogenesis eluted from two-dimensional gels. J. Biol. Chem. 273, 21769-21776.
28. Frank, R. & Overwin, H. (1996). Spot synthesis. In Methods in Molecular Biology, Vol. 66: Epitope Mapping Protocols. (Morris, G.E., ed.), pp. 149-169, Humana Press Inc., Totowa, NJ.
29. Jönsson, U., et al., & Malmqvist, M. (1991). Realtime biospecific interaction analysis using surface plasmon resonance and sensor chip technology. BioTechniques 11, 620-627.
30. Folli, S., et al., & Mach, J.P. (1994). Antibody-indocyanin conjugates for immunophotodetection of human squamous cell carcinoma in nude mice. Cancer Res. 53, 2643-2649.
31. Viti, F., Tarli, L., Giovannoni, L., Zardi, L. & Neri, D. (1999). Increased binding activity of recombinant antibody fragment lead to improved targeting of tumoural angiogenesis. Cancer Res., in press.
32. Leahy, D.J., Aukhil, I. & Erickson, H.P. (1996). 2.0 Å crystal structure of a four domain segment of human fibronectin encompassing the RGD loop and synergy region. Cell 84, 155-164.
33. Spitzfaden, C., Grant, R.P., Mardon, H.J. & Campbell, I.D. (1997). Module-module interactions in the cell binding region of fibronectin: Stability, flexibility and specificity. J. Mol. Biol. 265, 565-579.
34. Carnemolla, B., Leprini, A., Allemanni, G., Saginati, M. & Zardi, L. (1992). The inclusion of the type III repeat ED-B in the fibronectin molecule generates conformational modification that unmask a cryptic sequence. J. Biol. Chem. 267, 24689-24692.
35. Zhang, D.W., Burton-Wurster, N. & Lust, G. (1995). Antibody specific for extra domain B of fibronectin demonstrates elevated levels of both extra domain B(+) and B(-) fibronectin in osteoarthritic canine cartilage. Matrix Biol. 14, 623-633.
36. Peters, J.H., Trevithick, J.E., Johnson, P. & Hynes, R.O. (1995). Expression of the alternatively spliced EIIIB segment of fibronectin. Cell Adhesion Commun. 3, 67-89.
37. Winter, G., Griffiths, A.D., Hawkins, R.E. & Hoogenboom, H.R. (1994). Making antibodies by phage display technology. Annu. Rev. Immunol. 12, 433-455.
38. Mariani, G., et al., & Zardi, L. (1997). Tumor targeting potential of the monoclonal antibody BC-1 against oncofetal fibronectin in nude mice bearing human tumor implants. Cancer 80, 2378-2384.
39. Marion, D., Ikura, M., Tscudin, R. & Bax, A. (1989). Rapid recording of 2D NMR spectra without phase cycling: Application to the study of hydrogen exchange in proteins. J. Magn. Reson. 85, 393-399.
40. 2O solutions. J. Magn. Reson. 85, 608-613.
41. Bax, A. & Pochapsky, S.S. (1992). Optimized recording of heteronuclear multidimensional NMR spectra using pulsed field gradients. J. Magn. Reson. 99, 638-643.
42. Wider, G. & Wüthrich, K. (1993). A simple experimental scheme using pulsed field gradients for coherence pathway rejection and solvent suppression in phase-sensitive heteronuclear correlation spectra. J. Magn. Reson. 102, 239-241.
43. Güntert, P., Dötsch, V., Wider, G. & Wüthrich, K. (1992). Processing of multi-dimensional NMR data with the new software PROSA. J. Biomol. NMR 2, 619-629.
44. Bartels, C., Xia, T., Billeter, M., Güntert, P. & Wüthrich, K. (1995). The program XEASY for computer-supported NMR spectral analysis of biological macromolecules. J. Biomol. NMR 3, 1-10.
45. Güntert, P., Mumenthaler, C. & Wüthrich, K. (1997). Torsion angle dynamics for NMR structure calculation with new program DYANA. J. Mol. Biol. 273, 283-298.
46. Cornell, W.D., et al., & Kollman, P.A. (1995). A second generation force field for the simulation of proteins, nucleic acids, and organic molecules. J. Am. Chem. Soc. 117, 5179-5197.
47. Luginbühl, P., Güntert, P., Billeter, M. & Wüthrich, K. (1996). The new program OPAL for molecular dynamics simulations and energy refinements of biological macromolecules. J. Biomol NMR 8, 136-146.
48. Billeter, M., Schaumann, T., Braun, W. & Wüthrich K. (1990). Restrained energy refinement with two different algorithms and force fields of the structure of the α-amylase inhibitor Tendamistat determined by NMR in solution. Biopolymers 29, 695-706.
49. Koradi, R., Billeter, M. & Wüthrich, K. (1996). MOLMOL: A program for display and analysis of macromolecules structure. J. Mol. Graph. 14, 51-55.
50. Pini, A., Spreafico, A., Botti, R., Neri, D. & Neri, P. (1997). Hierarchical affinity maturation of a phage library derived antibody for the selective removal of cytomegalovirus from plasma. J. Immunol. Methods 206, 71-182.
51. Lavoie, T.B., Drohan, W.N. & Smith-Gill, S.J. (1992). Experimental analysis by site-directed mutagenesis of somatic mutation effects on affinity and fine specificity in antibodies specific for lysozyme. J. Immunol. 148, 503-513.
52. Leahy, D.J., Hendrickson, W.A., Aukhil, I. & Erickson, H.P. (1992). Structure of a fibronectin type III domain from tenascin phased by MAD analysis of the selenomethionyl protein. Science 258, 987-991.
53. Main, A.L., Harvey, T.S., Baron, M., Boyd, J. & Campbell, I.D. (1992). The three-dimensional structure of the tenth type III module of fibronectin: An insight into RGD-mediated interactions. Cell 71, 671-678.
54. Dickinson, C.D., et al., & Ely, K.R. (1994). Crystal structure of the tenth type III cell adhesion module of human fibronectin. J. Mol. Biol. 236, 1079-1092.
55. De Vos, A.M., Ultsch, M. & Kossiakoff, A.A. (1992). Human growth hormone and extracellular domain of its receptor: Crystal structure of the complex. Science 255, 306-312.
56. Huber, A.H, Wang, Y.M., Bieber, A.J. & Bjorkman, P.J. (1994). Crystal structure of tandem type III fibronectin domains from Drosophila neuroglian at 2.0 Å. Neuron 12, 717-731.
57. Copié, V., et al., & Torchia, D.A. (1998). Solution structure and dynamics of linked cell attachment modules of mouse fibronectin containing the RGD and synergy regions: Comparison with the human fibronectin crystal structure. J. Mol. Biol. 277, 663-682.